CLINICAL BENEFIT OF CABAZITAXEL PLUS PREDNISONE IN THE TROPIC TRIAL IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) WHO PROGRESSED AFTER DOCETAXEL-BASED TREATMENT
EUROPEAN UROLOGY SUPPLEMENTS, vol.10, no.2, pp.335-336, 2011 (SCI-Expanded)
- Publication Type: Article / Abstract
- Volume: 10 Issue: 2
- Publication Date: 2011
- Journal Name: EUROPEAN UROLOGY SUPPLEMENTS
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
- Page Numbers: pp.335-336
- Istanbul University Affiliated: Yes